University of Leicester-ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2018

  1. A phase ii multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

    Haematologica, Vol. 103, Núm. 8, pp. 1351-1358

2016

  1. Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia

    Leukemia, Vol. 30, Núm. 11, pp. 2179-2186

  2. Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

    Nature Communications, Vol. 7

2012

  1. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma

    British Journal of Haematology, Vol. 158, Núm. 6, pp. 712-726

2010

  1. Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies

    Blood, Vol. 116, Núm. 8, pp. 1317-1320

2009

  1. Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)

    Leukemia, Vol. 23, Núm. 11, pp. 2153-2155

  2. GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma

    British Journal of Haematology, Vol. 144, Núm. 3, pp. 317-331

2007

  1. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas

    Blood, Vol. 109, Núm. 1, pp. 271-280

2005

  1. Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays [4]

    Leukemia

2004

  1. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes

    Human Molecular Genetics, Vol. 13, Núm. 17, pp. 1827-1837

2003

  1. Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma

    Leukemia and Lymphoma, Vol. 44, Núm. 3, pp. 459-464

2002

  1. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci

    International Journal of Cancer, Vol. 98, Núm. 3, pp. 470-474

  2. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma

    Blood, Vol. 99, Núm. 4, pp. 1474-1477

2001

  1. Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma

    Blood, Vol. 98, Núm. 12, pp. 3479-3482